BEDFORD, Mass., April 04, 2016 (GLOBE NEWSWIRE) — ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants customized to fit each patient’s unique anatomy, today announced an update on its iTotal Hip submission to the United States Food and Drug Administration, or FDA.  As previously reported, ConforMIS submitted an application for 510(k) […]